These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 9803668)

  • 1. Quantitative structure-activity relationship of 4,5-diphenyl-2-(substituted thio)-1H-imidazoles as the inhibitors of acyl CoA: cholesterol acyltransferase.
    Singh P; Kumar R
    Indian J Biochem Biophys; 1998 Jun; 35(3):179-83. PubMed ID: 9803668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acyl-CoA:Cholesterol O-acyltransferase (ACAT) inhibitors. 2. 2-(1,3-Dioxan-2-yl)-4,5-diphenyl-1H-imidazoles as potent inhibitors of ACAT.
    Astles PC; Ashton MJ; Bridge AW; Harris NV; Hart TW; Parrott DP; Porter B; Riddell D; Smith C; Williams RJ
    J Med Chem; 1996 Mar; 39(7):1423-32. PubMed ID: 8691472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitors of acyl-CoA:cholesterol O-acyltransferase. synthesis and pharmacological activity of (+/-)-2-dodecyl-alpha-phenyl-N-(2,4,6-trimethoxyphenyl)-2H-tetrazole-5- acetamide and structurally related tetrazole amide derivatives.
    O'Brien PM; Sliskovic DR; Picard JA; Lee HT; Purchase CF; Roth BD; White AD; Anderson M; Mueller SB; Bocan T; Bousley R; Hamelehle KL; Homan R; Lee P; Krause BR; Reindel JF; Stanfield RL; Turluck D
    J Med Chem; 1996 Jun; 39(12):2354-66. PubMed ID: 8691430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of novel 4,5-diphenylthiazole derivatives as potential acyl-CoA:cholesterol O-acyltransferase inhibitors.
    Romeo G; Salerno L; Milla P; Siracusa M; Cattel L; Russo F
    Pharmazie; 1999 Jan; 54(1):19-23. PubMed ID: 9987793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and structure-activity relationship studies on a novel series of naphthylidinoylureas as inhibitors of acyl-CoA:cholesterol O-acyltransferase (ACAT).
    Ohnuma S; Muraoka M; Ioriya K; Ohashi N
    Bioorg Med Chem Lett; 2004 Mar; 14(5):1309-11. PubMed ID: 14980688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acyl CoA:cholesterol acyltransferase (ACAT) inhibitors: synthesis and structure-activity relationship studies of a new series of trisubstituted imidazoles.
    Higley CA; Wilde RG; Maduskuie TP; Johnson AL; Pennev P; Billheimer JT; Robinson CS; Gillies PJ; Wexler RR
    J Med Chem; 1994 Oct; 37(21):3511-22. PubMed ID: 7932580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. QSAR analyses of 3-(4-benzylpiperidin-1-yl)-N-phenylpropylamine derivatives as potent CCR5 antagonists.
    Roy K; Leonard JT
    J Chem Inf Model; 2005; 45(5):1352-68. PubMed ID: 16180912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological activity of novel 4-phenyl-1,8-naphthyridin-2(1H)-on-3-yl ureas: potent acyl-CoA:cholesterol acyltransferase inhibitor with improved aqueous solubility.
    Ban H; Muraoka M; Ioriya K; Ohashi N
    Bioorg Med Chem Lett; 2006 Jan; 16(1):44-8. PubMed ID: 16242323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel 3,5-diaryl pyrazolines as human acyl-CoA:cholesterol acyltransferase inhibitors.
    Jeong TS; Kim KS; An S; Cho KH; Lee S; Lee WS
    Bioorg Med Chem Lett; 2004 Jun; 14(11):2715-7. PubMed ID: 15125920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Saucerneol B derivatives as human acyl-CoA: cholesterol acyltransferase inhibitors.
    Jeong TS; Kim KS; Yu H; Kim MJ; Cho KH; Choi YK; Kim HC; Park HY; Lee WS
    Bioorg Med Chem Lett; 2005 Jan; 15(2):385-8. PubMed ID: 15603959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guineensine, an Acyl-CoA: cholesterol acyltransferase inhibitor, from the fruits of Piper longum.
    Lee SW; Rho MC; Nam JY; Lim EH; Kwon OE; Kim YH; Lee HS; Kim YK
    Planta Med; 2004 Jul; 70(7):678-9. PubMed ID: 15254860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acyl-CoA: cholesterol acyltransferase inhibitory activities of fatty acid amides isolated from Mylabris phalerate Pallas.
    Xu MZ; Lee WS; Kim MJ; Park DS; Yu H; Tian GR; Jeong TS; Park HY
    Bioorg Med Chem Lett; 2004 Aug; 14(16):4277-80. PubMed ID: 15261286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, biochemical evaluation, and classical and three-dimensional quantitative structure-activity relationship studies of 7-substituted-1,2,3,4-tetrahydroisoquinolines and their relative affinities toward phenylethanolamine N-methyltransferase and the alpha2-adrenoceptor.
    Grunewald GL; Dahanukar VH; Jalluri RK; Criscione KR
    J Med Chem; 1999 Jan; 42(1):118-34. PubMed ID: 9888838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Three dimensional quantitative structure-activity relationship of farnesyl protein transferase inhibitors].
    Wan SB; Yi X; Guo ZR
    Yao Xue Xue Bao; 2001 Jun; 36(6):423-6. PubMed ID: 12585125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological profile of SMP-797, a novel acyl-coenzyme a: cholesterol acyltransferase inhibitor with inducible effect on the expression of low-density lipoprotein receptor.
    Ioriya K; Kino K; Horisawa S; Nishimura T; Muraoka M; Noguchi T; Ohashi N
    J Cardiovasc Pharmacol; 2006 Feb; 47(2):322-9. PubMed ID: 16495773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and structure-activity relationship of pyripyropene A derivatives as potent and selective acyl-CoA:cholesterol acyltransferase 2 (ACAT2) inhibitors: part 3.
    Ohtawa M; Yamazaki H; Ohte S; Matsuda D; Ohshiro T; Rudel LL; Ōmura S; Tomoda H; Nagamitsu T
    Bioorg Med Chem Lett; 2013 Jul; 23(13):3798-801. PubMed ID: 23711919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting acyl-coenzyme A: cholesterol O-acyltransferase inhibitory activity: computational approach using topological descriptors.
    Lather V; Madan AK
    Drug Des Discov; 2003; 18(4):117-22. PubMed ID: 15553923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyacetylenic compounds, ACAT inhibitors from the roots of Panax ginseng.
    Rho MC; Lee HS; Lee SW; Chang JS; Kwon OE; Chung MY; Kim YK
    J Agric Food Chem; 2005 Feb; 53(4):919-22. PubMed ID: 15712998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel 3-arylamino- and 3-cycloalkylamino-5, 6-diphenyl-pyridazines active as ACAT inhibitors.
    Toma L; Giovannoni MP; Vergelli C; Dal Piaz V; Kwon BM; Kim YK; Gelain A; Barlocco D
    Arch Pharm (Weinheim); 2002; 335(11-12):563-6. PubMed ID: 12596221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and combinatorial synthesis of fungal metabolites beauveriolides, novel antiatherosclerotic agents.
    Tomoda H; Doi T
    Acc Chem Res; 2008 Jan; 41(1):32-9. PubMed ID: 17803269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.